| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 07/03/2017 | 21:32 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NYSE:STJ | ST. Jude Medical, Inc. |
| 07/03/2017 | 15:00 | PR Newswire (US) | Abbott Announces Results of Early Tenders and Consents in Exchange Offers and Execution of Supplemental Indenture | NYSE:STJ | ST. Jude Medical, Inc. |
| 14/02/2017 | 17:57 | Edgar (US Regulatory) | Amended Statement of Ownership (sc 13g/a) | NYSE:STJ | ST. Jude Medical, Inc. |
| 17/01/2017 | 20:45 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NYSE:STJ | ST. Jude Medical, Inc. |
| 13/01/2017 | 12:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NYSE:STJ | ST. Jude Medical, Inc. |
| 10/01/2017 | 19:24 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NYSE:STJ | ST. Jude Medical, Inc. |
| 06/01/2017 | 19:58 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:STJ | ST. Jude Medical, Inc. |
| 05/01/2017 | 22:27 | Edgar (US Regulatory) | Current Report Filing (8-k) | NYSE:STJ | ST. Jude Medical, Inc. |
| 04/01/2017 | 22:42 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NYSE:STJ | ST. Jude Medical, Inc. |
| 04/01/2017 | 22:04 | Edgar (US Regulatory) | (25-NSE) | NYSE:STJ | ST. Jude Medical, Inc. |
| 04/01/2017 | 00:35 | PR Newswire (US) | IDEXX Laboratories Set to Join the S&P 500; Chemours to Join S&P MidCap 400; Shake Shack to Join S&P SmallCap 600 | NYSE:STJ | ST. Jude Medical, Inc. |
| 16/12/2016 | 18:22 | Business Wire | St. Jude Medical gibt FDA-Freigabe des Systems EnSite Precision zur Abbildung der Herzanatomie bekannt | NYSE:STJ | ST. Jude Medical, Inc. |
| 16/12/2016 | 01:29 | Business Wire | St. Jude Medical annonce avoir obtenu l'approbation de la FDA pour son système de cartographie cardiaque Ensite Precision | NYSE:STJ | ST. Jude Medical, Inc. |
| 15/12/2016 | 14:00 | Business Wire | St. Jude Medical Announces FDA Clearance of EnSite Precision Cardiac Mapping System | NYSE:STJ | ST. Jude Medical, Inc. |
| 09/12/2016 | 22:02 | Business Wire | St. Jude Medical Announces Fourth Quarter Dividend | NYSE:STJ | ST. Jude Medical, Inc. |
| 09/12/2016 | 02:24 | Business Wire | St. Jude Medical reçoit l’autorisation de marquage CE d’étiquetage conditionnel RM du corps entier pour le système de... | NYSE:STJ | ST. Jude Medical, Inc. |
| 08/12/2016 | 14:00 | Business Wire | St. Jude Medical Receives CE Mark Approval for Full Body MR Conditional Labeling for the Proclaim Elite Spinal Cord Stimulati... | NYSE:STJ | ST. Jude Medical, Inc. |
| 16/11/2016 | 18:34 | Business Wire | St. Jude Medical HeartMate 3 LVAS Demonstrated Improved Clinical Outcomes for Patients Suffering from Advanced Heart Failure | NYSE:STJ | ST. Jude Medical, Inc. |
| 14/11/2016 | 14:00 | Business Wire | St. Jude Medical Announces Full-Body MRI Compatibility & Second Major Upgrade for Proclaim Elite Spinal Cord Stimulation System | NYSE:STJ | ST. Jude Medical, Inc. |
| 09/11/2016 | 17:00 | Business Wire | St. Jude Medical obtient le marquage CE pour la compatibilité IRM de son stimulateur de resynchronisation cardiaque Quadra A... | NYSE:STJ | ST. Jude Medical, Inc. |
| 07/11/2016 | 22:37 | Edgar (US Regulatory) | Quarterly Report (10-q) | NYSE:STJ | ST. Jude Medical, Inc. |
| 07/11/2016 | 14:00 | Business Wire | St. Jude Medical Gains CE Mark Approval for MRI Labeling of its Quadra Allure MP Cardiac Resynchronization Therapy Pacemaker | NYSE:STJ | ST. Jude Medical, Inc. |
| 03/11/2016 | 01:05 | Business Wire | La plus vaste étude observationnelle jamais réalisée sur le dispositif de fermeture de l'appendice auriculaire gauche AMPL... | NYSE:STJ | ST. Jude Medical, Inc. |
| 03/11/2016 | 01:05 | Business Wire | Größte Beobachtungsstudie des St. Jude Medical AMPLATZER Amulet Left Atrial Appendage Occluder bis dato zeigt großen Impla... | NYSE:STJ | ST. Jude Medical, Inc. |
| 02/11/2016 | 15:05 | Business Wire | Largest Observational Study to Date of the St. Jude Medical AMPLATZER Amulet Left Atrial Appendage Occluder Demonstrates High... | NYSE:STJ | ST. Jude Medical, Inc. |
| 01/11/2016 | 19:20 | Business Wire | St. Jude Medical begrüßt wegweisende Daten zu Schlaganfällen aus der RESPECT-Studie | NYSE:STJ | ST. Jude Medical, Inc. |
| 01/11/2016 | 17:31 | Business Wire | St. Jude Medical est satisfaite des données décisives sur les accidents vasculaires cérébraux issues de l’essai RESPECT | NYSE:STJ | ST. Jude Medical, Inc. |
| 01/11/2016 | 17:31 | Business Wire | St. Jude Medical Welcomes Landmark Stroke Data from the RESPECT Trial | NYSE:STJ | ST. Jude Medical, Inc. |
| 31/10/2016 | 12:11 | Business Wire | Les résultats de l'essai clinique ILUMIEN III réalisé par St. Jude Medical offrent des conclusions importantes en termes d... | NYSE:STJ | ST. Jude Medical, Inc. |
| 30/10/2016 | 14:27 | Business Wire | ILUMIEN III Clinical Trial Results from St. Jude Medical Demonstrate Important Findings with Advanced Intravascular Imaging T... | NYSE:STJ | ST. Jude Medical, Inc. |